ESTRADIOL recalled over manufacturing violations
- Recall date
- April 3, 2017
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Medisca, Inc. recalls ESTRADIOL, USP Bulk (Hemihydrate), in a) 25 g (NDC 38779-2261-04) and b) 100 g (NDC 38779-2261-05) bottles, Packed by M…
- Recall number
- D-0666-2017
- FDA classification
- Class II
- Brand / firm
- Medisca, Inc.
- Sold / distributed
- Nationwide, Australia, Bahamas, Italy, Singapore, Thailand, United Kingdom
Why it was recalled
cGMP Deviations; manufacturer initiated recall of API product after deficiencies noted during a recent FDA inspection
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
ESTRADIOL, USP Bulk (Hemihydrate), in a) 25 g (NDC 38779-2261-04) and b) 100 g (NDC 38779-2261-05) bottles, Packed by MEDISCA INC. PLATTSBURGH, NY Product Code 2261
Get recall alerts
Free email alert whenever Medisca, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Medisca, Inc.